Terminology Service < Semantic Lookup Platform

All terms in NCIT

Label	Id	Description
MMSE-2 Standard Version - Level of Consciousness	NCIT_C151026	[Mini-Mental State Examination 2 Standard Version (MMSE-2 Standard Version) Assessment of level of consciousness.]
Needle Tract Lesion	NCIT_C126089	[A localized pathological or traumatic structural change due to insertion and/or withdrawal of a needle.]
Percent Predicted Functional Residual Capacity	NCIT_C126052	[The volume of air remaining in the lungs after a normal exhalation as a proportion of the predicted normal value. (CDISC)]
Pulmonary Function Test	NCIT_C38081	[A broad range of tests that are performed to assess how well lungs inhale and exhale air and how efficiently they transfer oxygen into the blood.]
Exhaled Breath Condensate	NCIT_C126053	[Expired air that has been condensed.]
Expired Air	NCIT_C78741	[The air that moves out of the chest during expiration. It contains a higher percentage of carbon dioxide and a lower percentage of oxygen compared to the inhaled air.]
MMSE-2 Standard Version - What is 100 Take Away 7	NCIT_C151010	[Mini-Mental State Examination 2 Standard Version (MMSE-2 Standard Version) What is 100 take away 7 [93]?]
Non-Pathological	NCIT_C126054	[The absence of disease or pathology.]
Disease Qualifier	NCIT_C27992	[An adjectival term used to specify and describe a disease appearance or processes.]
Present Without Unequivocal Progression	NCIT_C126055	[There is evidence of disease without evidence of unequivocal progression.]
Disease Response	NCIT_C50995	[The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.]
MMSE-2 Standard Version - Keep Subtracting 7 Step 2	NCIT_C151011	[Mini-Mental State Examination 2 Standard Version (MMSE-2 Standard Version) Keep going [86].]
Guidelines for Management of Breast Cancer WHO 2006	NCIT_C126050
Wolchok Solid Tumors 2009 Oncology Response Criteria	NCIT_C126051	[A measure proposed by Wolchok et al. (Clin Cancer Res 2009;15:7412-7420) to determine the extent of an antitumor response to a particular immunotherapeutic agent.]
MMSE-2 Standard Version - Naming Object 2	NCIT_C151016	[Mini-Mental State Examination 2 Standard Version (MMSE-2 Standard Version) What is this: Object 2?]
MMSE-2 Standard Version - Repeat What I Say	NCIT_C151017	[Mini-Mental State Examination 2 Standard Version (MMSE-2 Standard Version) Now I am going to ask you to repeat what I say. Ready? "It is a lovely, sunny day but too warm." Now you say that.]
MMSE-2 Standard Version - Point to the Circle	NCIT_C151018	[Mini-Mental State Examination 2 Standard Version (MMSE-2 Standard Version) Look at these pictures and point to the circle.]
MMSE-2 Standard Version - Point to the Square	NCIT_C151019	[Mini-Mental State Examination 2 Standard Version (MMSE-2 Standard Version) Then point to the square.]
MMSE-2 Standard Version - Keep Subtracting 7 Step 3	NCIT_C151012	[Mini-Mental State Examination 2 Standard Version (MMSE-2 Standard Version) Keep going [79].]
MMSE-2 Standard Version - Keep Subtracting 7 Step 4	NCIT_C151013	[Mini-Mental State Examination 2 Standard Version (MMSE-2 Standard Version) Keep going [72].]